Population Health Partners
Overview
Investment portfolio
| NAME | DATE | SIZE | |
|---|---|---|---|
Corsera Health | Jan 2026Led | $80 MSeries A | |
Areteia Therapeutics | Feb 2024Participated | $75 MSeries A | |
Areteia Therapeutics | Jul 2022Participated | $350 MSeries A | |
Saama | Oct 2021Participated | $430 MOther Equity | |
Fractyl Health | Jun 2021Led | $100 MSeries F | |
Invivyd | Apr 2021Participated | $336 MSeries C | |
New Amsterdam Pharma | Jan 2021Participated | $195 MSeries A | |
Invivyd | Nov 2020Participated | $80 MSeries B | |
Corsera Health | Jan 2026Led | $80 MSeries A | |
Areteia Therapeutics | Feb 2024Participated | $75 MSeries A | |
Areteia Therapeutics | Jul 2022Participated | $350 MSeries A | |
Saama | Oct 2021Participated | $430 MOther Equity | |
Fractyl Health | Jun 2021Led | $100 MSeries F | |
Invivyd | Apr 2021Participated | $336 MSeries C | |
New Amsterdam Pharma | Jan 2021Participated | $195 MSeries A | |
Invivyd | Nov 2020Participated | $80 MSeries B |
Insights
Time horizon
View by
Deal Distribution
| Round type | Led deals | Participated deals |
|---|---|---|
| Series A | 1 | 3 |
| Series B | 0 | 1 |
| Series C+ | 1 | 1 |
| Other Equity | 0 | 1 |
Monthly Deal Activity
| Month | Deals |
|---|---|
| Nov '20 | 1 |
| Dec '20 | 0 |
| Jan '21 | 1 |
| Feb '21 | 0 |
| Mar '21 | 0 |
| Apr '21 | 1 |
| May '21 | 0 |
| Jun '21 | 1 |
| Jul '21 | 0 |
| Aug '21 | 0 |
| Sep '21 | 0 |
| Oct '21 | 1 |
| Nov '21 | 0 |
| Dec '21 | 0 |
| Jan '22 | 0 |
| Feb '22 | 0 |
| Mar '22 | 0 |
| Apr '22 | 0 |
| May '22 | 0 |
| Jun '22 | 0 |
| Jul '22 | 1 |
| Aug '22 | 0 |
| Sep '22 | 0 |
| Oct '22 | 0 |
| Nov '22 | 0 |
| Dec '22 | 0 |
| Jan '23 | 0 |
| Feb '23 | 0 |
| Mar '23 | 0 |
| Apr '23 | 0 |
| May '23 | 0 |
| Jun '23 | 0 |
| Jul '23 | 0 |
| Aug '23 | 0 |
| Sep '23 | 0 |
| Oct '23 | 0 |
| Nov '23 | 0 |
| Dec '23 | 0 |
| Jan '24 | 0 |
| Feb '24 | 1 |
| Mar '24 | 0 |
| Apr '24 | 0 |
| May '24 | 0 |
| Jun '24 | 0 |
| Jul '24 | 0 |
| Aug '24 | 0 |
| Sep '24 | 0 |
| Oct '24 | 0 |
| Nov '24 | 0 |
| Dec '24 | 0 |
| Jan '25 | 0 |
| Feb '25 | 0 |
| Mar '25 | 0 |
| Apr '25 | 0 |
| May '25 | 0 |
| Jun '25 | 0 |
| Jul '25 | 0 |
| Aug '25 | 0 |
| Sep '25 | 0 |
| Oct '25 | 0 |
| Nov '25 | 0 |
| Dec '25 | 0 |
| Jan '26 | 1 |
| Feb '26 | 0 |
| Mar '26 | 0 |
| Apr '26 | 0 |
| May '26 | 0 |
| Jun '26 | 0 |
| Jul '26 | 0 |
| Aug '26 | 0 |
| Sep '26 | 0 |
| Oct '26 | 0 |
Sector Breakdown
A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.
| Sector | Deals |
|---|---|
| Health & Life Sciences | 8 |
| Enterprise Software | 1 |
| AI & Machine Learning | 1 |
| Data, Analytics & IT | 1 |
Deal Size Distribution
Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.
| Round size band (USD) | Deals |
|---|---|
| <$5M | 0 |
| $5M-$10M | 0 |
| $10M-$25M | 0 |
| $25M-$50M | 0 |
| $50M-$100M | 3 |
| $100M-$250M | 2 |
| $250M-$500M | 3 |
| $500M-$1B | 0 |
| $1B+ | 0 |
Deals By Geography
Top 2 of 2 regions; European countries are grouped as Europe.
| Region | Deals |
|---|---|
| United States | 7 |
| Europe | 1 |
Co-Investors
Bubble size = shared deals
Click a bubble to open that fund in a new tab.
Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.
| Co-investor | Shared deals |
|---|---|
| Google Ventures | 4 |
| Maverick Capital | 3 |
| Access Biotechnology | 2 |
| ARCH Venture Partners | 2 |
| Bain Capital Life Sciences | 2 |
| Fidelity Management & Research Company | 2 |
| Forbion | 2 |
| Mithril Capital Management | 2 |
| Omega Funds | 2 |
| OrbiMed | 2 |
| Polaris Partners | 2 |
| Sanofi | 2 |
| Saturn Partners | 2 |
| Adimab | 1 |
| Amgen Ventures | 1 |
| ArrowMark Partners | 1 |
| Ascendant BioCapital | 1 |
| BVF Partners | 1 |
| Carlyle | 1 |
| EQT Life Sciences (LSP) | 1 |
Investment Strategy
| Category | Deals (count) | Share (%) |
|---|---|---|
| Led | 2 | 25% |
| Participating | 6 | 75% |
| Category | Deals (count) | Share (%) |
|---|---|---|
| Single-lead | 0 | 0% |
| Co-led | 2 | 100% |
Team
Executive Chairman & Co-Founder
Partner
Venture Partner
Chief Digital Officer
Managing Partner